SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.170+3.5%Jan 21 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: hpgrant who wrote (10273)5/15/2018 2:42:06 PM
From: NanoPenguin2 Recommendations

Recommended By
Another_Voice_2
mattstat

  Read Replies (1) of 12873
 
Dear Dr. Diwan,
NanoViricides reports that it does not know of the reasons for a recent sharp decline in its stock price. The Company's current drug candidates in the HerpeCide™ program are moving towards the clinical stage steadily. The Company is diligently working towards obtaining all the information that we will need for filing our first Investigational New Drug application (IND).
I am your long term faithful investor since 2005 (EDOT.com days). A lot of capital has been lost by shareholders that were supporting your dreams for years. I was surprised that you do not know why the stock price is going down. I was led to believe by you at the shareholder's meeting and other communications that the shinglescide candidate was moving forward right after the pre-tox was done. You mention nothing about the status of this in your 'update' PR. There is not even a pre-IND meeting set up as promised. I have no clue as to what the company is really doing since none of the plans never seem to come through. Your update does not even mention shinglescide. You told us all that this is the lead candidate. If that is no longer true, the shareholders should know. How can you not know why the stock price is going down? Also, I was led to believe that the licensing of shinglescide to NNVC was a mere formality and was being worked on and nothing ever happened. This should have been done already without question or the shareholders told what the problem is. Not promptly licensing shinglescide to NNVC causes distrust. The vague, misleading communications are unfair to us shareholders. I think the best thing this company can do is to vastly improve its communication to be open, honest and transparent.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News